Marco Aurelio Lana-Peixoto
Overview
Explore the profile of Marco Aurelio Lana-Peixoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oertel F, Zimmermann H, Motamedi S, Bereuter C, Asseyer E, Chien C, et al.
J Neuroophthalmol
. 2025 Jan;
44(4):e554-e557.
PMID: 39808514
No abstract available.
2.
Oertel F, Zimmermann H, Motamedi S, Chien C, Aktas O, Albrecht P, et al.
J Neurol Neurosurg Psychiatry
. 2023 Feb;
94(7):560-566.
PMID: 36810323
Background: The novel optic neuritis (ON) diagnostic criteria include intereye differences (IED) of optical coherence tomography (OCT) parameters. IED has proven valuable for ON diagnosis in multiple sclerosis but has...
3.
Dos Passos G, Becker J, Varela D, Frohlich A, Rech B, Mattos A, et al.
Arq Neuropsiquiatr
. 2021 Sep;
79(8):692-696.
PMID: 34550189
Background: To improve the comparability of multiple sclerosis (MS) prevalence across Brazilian regions, the Brazilian Committee for Treatment and Research in MS has implemented a standardized approach to assess the...
4.
Marin C, Callegaro D, Lana-Peixoto M, Fernandez O, Gomes Neto A, Vasconcelos C, et al.
Arq Neuropsiquiatr
. 2021 Sep;
79(7):598-606.
PMID: 34468497
Background: Recent changes to the diagnostic criteria for multiple sclerosis (MS) and new medications have had a major impact on the way in which specialists manage the disease. Objective: To...
5.
Goncalves M, Siquineli F, Ribas F, Longo A, Amaral C, Chikota E, et al.
Arq Neuropsiquiatr
. 2021 Mar;
79(2):122-126.
PMID: 33759978
Background: The Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS) has launched an initiative to determine the prevalence of multiple sclerosis (MS) in Brazil, based on key cities...
6.
Marin C, Kfouri P, Callegaro D, Lana-Peixoto M, Gomes Neto A, Vasconcelos C, et al.
Mult Scler Relat Disord
. 2021 Feb;
50:102806.
PMID: 33588316
Background: Basic steps in the management of patients with Multiple Sclerosis (MS), such as good patient understanding of the disease and active participation in its management are extremely important, as...
7.
Marques V, Dos Passos G, Mendes M, Callegaro D, Lana-Peixoto M, Comini-Frota E, et al.
Arq Neuropsiquiatr
. 2018 Sep;
76(8):539-554.
PMID: 30231128
The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In...
8.
Damasceno A, Amaral J, Barreira A, Becker J, Callegaro D, Campanholo K, et al.
Arq Neuropsiquiatr
. 2018 May;
76(3):163-169.
PMID: 29809236
Objective Cognitive dysfunction is common in multiple sclerosis. The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) was developed to assess cognitive functions most-frequently impaired in multiple sclerosis. However, normative values...
9.
Becker J, Callegaro D, Lana-Peixoto M, Talim N, Vidaletti T, de Paula Correa M, et al.
J Neurol Sci
. 2016 Mar;
363:236-9.
PMID: 27000256
Multiple sclerosis (MS) onset is believed to result from a combination of environmental and genetic factors. A prevailing theory addresses the influence of hypovitaminosis D in the development of MS....
10.
da Gama P, Machado L, Livramento J, Gomes H, Adoni T, de Rizo Morales R, et al.
Biomed Res Int
. 2015 Aug;
2015:217961.
PMID: 26295036
Genetic susceptibility is a well-recognized factor in the onset of multiple sclerosis (MS). The objective of this study was to determine the frequency of oligoclonal bands (OCB) restricted to the...